Aizen Therapeutics
Develops AI-driven Mirror Peptides, a novel class of biologic medicines, to treat neurological disorders, cancers, and genetic diseases.
HQ location
San Diego, United States
Website
Launch date
Enterprise value
$52—78m
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $13.0m | Seed | |
| Total Funding | 000k | ||
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads